Axsome Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Axsome Therapeutics (AXSM) Reports Q4 Loss Per Share of $0.12
March 24, 2016 4:31 PM EDTAxsome Therapeutics (NASDAQ: AXSM) reported Q4 EPS of ($0.12), versus ($0.14) reported last year.
For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.
... More
